Top compounds associated with response to SPRY2


Feature Type Standardized
Nominal ANOVA
mRNA GDC-0879 CTRPv2 pan-cancer AAC 0.29 7e-15
mRNA AZD6244 CTRPv2 pan-cancer AAC 0.29 3e-14
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.29 4e-14
mRNA dabrafenib GDSC1000 pan-cancer AAC 0.23 5e-12
mRNA AS605240 GDSC1000 pan-cancer AAC 0.24 7e-11
mRNA (5Z)-7-Oxozeaenol GDSC1000 pan-cancer AAC 0.22 2e-10
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.23 5e-10
mRNA dabrafenib CTRPv2 pan-cancer AAC 0.31 9e-10
mRNA VX-11e GDSC1000 pan-cancer AAC 0.22 2e-09
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.23 3e-09
Download CSV